Human papillomaviruses in Western Africa: prevalences and risk factors in Burkina Faso

Maria, Hatzipanagiotou; Holzinger, Dana; Françoise, M; Pawlita, Michael; Wacker, Jürgen

doi:10.1007/s00404-018-4860-z

Cited by 7 publications

(4 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, based on global based reviews the prevalence of HPV was between 11 and 12% (with higher rates in sub-Saharan Africa at 24%) in women without cervical abnormalities [7,15]. Similarly, in other global based reviews analogous findings were reported on this regard at 22.1% in Africa, 20.4% in Central America and Mexico, 11.3% in northern America, 8.1% in Europe and 8.0-12.8% in Asia [12,27], specifically 9.4% in Iran [22] and 14.71-44.3% in China [9,32] and 42.3% in Burkina Faso [23]. The difference regarding the report from Burkina Faso and China could be explained by a population difference in which these studies might be included woman with cervical abnormalities.…”

Section: Discussionsupporting

confidence: 71%

“…Besides, a review by Pend et al [27] conducted to demonstrate the HPV genotype among Asian women reported HPV prevalence at 84.8% from different kinds of advanced cervical lesions. Furthermore, other review studies from different corner of the globe reported the following ranges of HPV prevalence from different grades of cervical dysplasia; 87.2% (Burkina Faso) [23], between 70 and 80% (North America) [11], 78.1% (Central and Eastern Europe) [28] and between 64.8 and 90.1% (Thai) [18].…”

Section: Discussionmentioning

confidence: 98%

See 1 more Smart Citation

Human papillomavirus in Ethiopia

et al. 2019

View full text Add to dashboard Cite

Over 99% of cervical cancer cases are associated with genital infection by certain types of human papillomaviruses (HPVs). To outline optimal vaccination strategies and HPV based cervical cancer screening, synthesized data on the genotype distribution of HPV is fundamental that is otherwise missed in Ethiopia. The aim of this study is to compile the findings on HPV genotyping in Ethiopia. Published articles were systematically searched using comprehensive search strings from PubMed/Medline and SCOPUS. Further, Google Scholar and the Google databases were also searched manually for grey literature. The included studies in the review employed 859 women (age range 15-85 years) with different kinds of cervical abnormalities. A total of 534 HPV sequences were reported; the proportion of high risk HPVs was varied 80.4-100%. The top five identified genotypes were HPV 16 (45.3%; 95% CI 41.1-49.6%), HPV 52 (9.4%; 95% CI 7.2-12.1%), HPV 18 (8.2%; 95% CI 6.2-10.9%), HPV 58 (6.9%; 95% CI 5.1-9.4%) and HPV 45 (5.2%; 95% CI 3.7-7.5%). The combined prevalence of HPV 16/18 was at 53.6% (95% CI 49.3-57.8%). In this review, HPV 16 in particular, but also HPV 52 and 18, warrant exceptional consideration in vaccination and HPV based screening programs in Ethiopia. To the best of our knowledge, this study represents the first of its kind to establish the genotype distribution of HPV from different kinds of cervical lesions in Ethiopia although it was synthesized out of few studies. Hence, additional nationwide data are needed to strengthen our finding.

show abstract

Section: Discussionsupporting

confidence: 71%

Section: Discussionmentioning

confidence: 98%

Human papillomavirus in Ethiopia

et al. 2019

View full text Add to dashboard Cite

show abstract

“…9 A study of United States in 2005 showed that the incidence of oncogenic HPV infection was approximately 15.1%. 10 In relatively underdeveloped economic areas, such as Western Africa, there was a study showed that high-risk HPV infection rate was 28.6%, 11 and in Kazakhstan, the overall HPV prevalence rate was as high as 43.8%-55.8%. 12 Within China, the HPV infection rate in different regions was also significantly different, ranging from 13% to 31.9%, [13][14][15] the HPV infection rate in economically developed areas was significantly lower than in economically undeveloped areas.…”

Section: Discussionmentioning

confidence: 99%

Epidemiology and analysis of potential risk factors of high‐risk human papillomavirus (HPV) in Shanghai China: A cross‐sectional one‐year study in non‐vaccinated women

Niu

Pan

Wei

et al. 2021

Journal of Medical Virology

View full text Add to dashboard Cite

Data regarding human papillomavirus (HPV) prevalence, its associated risk factors, and women's knowledge about this disease before the HPV vaccine was approved are limited in Shanghai, China. Therefore, we investigated these questions among females in Shanghai and aimed to provide comprehensive data to guide HPV vaccination and present the biopsychosocial risk factors that impact high-risk HPV infection, and evaluate the level of knowledge and awareness of this disease among women aged

show abstract

“…The highest prevalence rates have been reported in Sub Saharan Africa (24.00%), Latin America and the Caribbean (16.10%), Eastern Europe (14.20%), and South East Asia (14.00%) ( Bekmukhambetov et al, 2016 ). A study in the economically underdeveloped regions of West Africa showed that the high-risk HPV infection rate of 28.6% ( Maria et al, 2018 ), whereas the overall HPV prevalence rate in Kazakhstan was reported to be as high as 43.8–55.8% ( Aimagambetova and Azizan, 2018 ).…”

Section: Introductionmentioning

confidence: 99%

Risk Factors Associated With Human Papillomavirus Infection, Cervical Cancer, and Precancerous Lesions in Large-Scale Population Screening

et al. 2022

View full text Add to dashboard Cite

Cervical cancer is the most common gynecological malignancy and screening for risk factors with early detection has been shown to reduce the mortality. In this study, we aimed to analyze the characteristics and risk factors of human papillomavirus (HPV) infection and precancerous lesions in women and provide clinical evidence for developing strategies to prevent cervical precancerous lesions and cancer in women. Furthermore, we evaluated the influencing factors for high-risk HPV infection. From April 2018 to December 2021, 10,628 women were recruited for cervical cancer screening at Liaoning Cancer Hospital, Shenyang Sujiatun District Women’s and Infants Hospital, Benxi Manchu Autonomous County People’s Hospital, and Shandong Affiliated Hospital of Qingdao University. The study participants were tested to determine if they were HPV-positive (HPV +) or underwent thinprep cytology test (TCT) for atypical squamous cells of undetermined significance (ASCUS) and above. Furthermore, colposcopies and biopsies were performed for the histopathological examination. Finally, 9991 cases were included in the statistical analysis, and the factors influencing HPV infection and those related to cervical cancer and precancerous lesions were analyzed. HPV + infection, high-grade squamous intraepithelial lesion-positive (CINII +) in cervical high-grade intraepithelial neoplasia, and early cervical cancer diagnosis rates were 12.45, 1.09, and 95.41%, respectively. The potential risk factors for HPV were education ≤ high school [odds ratio (OR) = 1.279 (1.129–1.449), P < 0.001], age at initial sexual activity ≤ 19 years [OR = 1.517 (1.080–2.129), P = 0.016], sexual partners > 1 [OR = 1.310 (1.044–1.644), P = 0.020], ASCUS and above [OR = 11.891 (10.105–13.993), P < 0.001], non-condom contraception [OR = 1.255 (1.059–1.487), P = 0.009], and HSIL and above [OR = 1.541 (1.430–1.662), P < 0.001]. Compared with women aged 56–65 and 35–45 years [OR = 0.810 (0.690–0.950), P = 0.010] the HPV infection rate was significantly lower in those aged 46–55 years [OR = 0.79 (0.683–0.915), P = 0.002]. Furthermore, ≤ high school age [OR = 1.577 (1.042–2.387), P = 0.031], not breastfeeding [OR = 1.763 (1.109–2.804), P = 0.017], ASCUS and above [OR = 42.396 (28.042–64.098), P < 0.001] were potential risk factors for cervical cancer and precancerous lesions. In women with HPV infection, ≤ high school education level, initial sexual activity at ≤ 19 years of age, number of sexual partners > 1, ASCUS and above, non-condom contraception, HSIL and above were risk factors for HPV infection. Compared with women aged 56–65 years, those aged 35–45 and 46–55 years had significantly lower HPV infection rates, and high school age and below, non-breastfeeding, and ASCUS and above were all potential risk factors for cervical cancer and precancerous lesions.

show abstract

Human papillomaviruses in Western Africa: prevalences and risk factors in Burkina Faso

Abstract: The prevention of infection with human papillomaviruses by vaccination is expected to result in a drastic reduction in the morbidity and mortality of the cervical cancer in Burkina Faso.

Cited by 7 publications

References 28 publications

Human papillomavirus in Ethiopia

Human papillomavirus in Ethiopia

Epidemiology and analysis of potential risk factors of high‐risk human papillomavirus (HPV) in Shanghai China: A cross‐sectional one‐year study in non‐vaccinated women

Risk Factors Associated With Human Papillomavirus Infection, Cervical Cancer, and Precancerous Lesions in Large-Scale Population Screening

Contact Info

Product

Resources

About